Research of Molecular and Metabolic Diagnostic Markers in Oligodendrogliomas A and B Comparatively.
N/A
1 Year
N/A
1 Year
N/A
Not Enrolling
Both
Oligodendrogliomas
Both
Oligodendrogliomas
Trial Information
Research of Molecular and Metabolic Diagnostic Markers in Oligodendrogliomas A and B Comparatively.
Inclusion Criteria:
- Paediatric and adult patients (> 1 year of age)
- Patient with oligodendroglioma or medulloblastoma or glioma
- Possibility of 3 year follow-up
- Patient consent obtained
Exclusion Criteria:
-
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Prospective
Principal Investigator
Natacha Entz-Werle, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Hopitaux Universitaires de Strasbourg
Authority:
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Study ID:
3154
NCT ID:
NCT00213876
Start Date:
February 2004
Completion Date:
August 2011
Related Keywords:
- Oligodendrogliomas
- Brain tumours
- oligodendrogliomas
- allelotyping
- SAGE
- Presence of molecular abnormalities statistically linked to survival or response to chemotherapy
- Brain Neoplasms
- Oligodendroglioma
Name | Location |
|---|
